Financials
- Market Capitalization 31.76 M
- Employee 25
- Founded 2000
- CEO Sandesh Seth
- Website www.actiniumpharma.com
- Headquarter Delaware, United States
- FIGI BBG000RQZ245
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.25
ratio cours/chiffre d'affaires
471.4
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4431 | BCTX BriaCell Therapeutics Corp. - Common Shares | 3.73 USD | +0.54% | -7.67% | +6.88% | -51.24% | 32.45 M USD | ||
| 4437 | IGC IGC Pharma, Inc. Common Stock | 0.31 USD | -6.06% | +3.33% | +24.00% | +21.00% | 32.05 M USD | ||
| 4445 | ESLA Estrella Immunopharma, Inc. - Common Stock | 0.71 USD | -1.39% | -6.58% | -6.58% | -33.02% | 30.88 M USD | ||
| 4449 | BRNS Barinthus Biotherapeutics plc - American Depositary Shares | 0.75 USD | 0.00% | +19.05% | +36.36% | -39.02% | 30.64 M USD |